CLEVELAND, Nov. 12, 2019 /PRNewswire/ -- ViewRay, Inc. (Nasdaq: VRAY) today announced financial results for the third quarter ended September 30, 2019.

SALT LAKE CITY, Nov. 12, 2019 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company, today announced financial results for the third quarter and nine months ended September 30, 2019, and provided a corporate update.

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- On November 14th, Yankee Stadium will transform from the world's most iconic ballpark into a beacon of hope for young people overcoming homelessness.That's when Yankees General Manager Brian Cashman will join over 200 other leaders to sleep at the Stadiu

ALEXANDRIA, Va., Nov. 12, 2019 /PRNewswire/ -- While the holidays are a very social time of year, they can also be a very lonely time for many people. The Better Sleep Council&nb

SAN CARLOS, Calif. and WASHINGTON, Nov. 12, 2019 /PRNewswire/ -- GO2 Foundation for Lung Cancer (a merger of the Bonnie J. Addario Lung

RANCHO CORDOVA, Calif., Nov. 12, 2019 /PRNewswire/ -- ThermoGenesis Holdings, Inc. (Nasdaq: THMO), formerly known as Cesca Therapeutics Inc., a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced it will delay its third quarter ended September 30, 2019 earnings release a

ATLANTA, Nov. 12, 2019 /PRNewswire/ -- Rehabilitation after knee replacement is an essential part of the recovery process. But what's the best way to prepare patients before the procedure? Researchers at Hospital for Special Surgery (HSS) in New York City launched a pilot study to find out if a "pre-habilitation" program &ndas

NEW YORK, Nov. 12, 2019 /PRNewswire/ -- Today the Lung Cancer Research Foundation® (LCRF) announced the awardees of its 2019 Scientific Grant Program during the Fourteenth Annual Lung Cancer Awareness Luncheon, held at The Pierre in New York City. Through this program, LCRF awarded $2.6 m

AUSTIN, Texas, Nov. 12, 2019 /PRNewswire/ -- Intiva Health announced that Craig Reid has joined the organization as General Counsel.

IRVINE, Calif., Nov. 12, 2019 /PRNewswire/ -- AIVITA Biomedical, Inc., a biotech company specializing in innovative stem cell applications, today announced that data from its ongoing Phase 2 clinical trial in GBM was presented at the Society for Immunotherapy of Cancer Annual Meeting by Principal Investigator Dr. Daniela Bota. The oral pres